Annamaria Biczok

Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma

Bogdana Suchorska, Armin Giese, Annamaria Biczok et al. · Neuro-Oncology · 2017 · 84 citations · Full text

PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging

Adrien Holzgreve, Annamaria Biczok, Viktoria Ruf et al. · Frontiers in Oncology · 2021 · 73 citations · Full text

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas

Annamaria Biczok, Theo F. J. Kraus, Bogdana Suchorska et al. · Journal of Neuro-Oncology · 2018 · 67 citations

Somatic Variant, Medicine, Genetics +7

Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning

Bogdana Suchorska, Ulrich Schüller, Annamaria Biczok et al. · European Journal of Cancer · 2018 · 57 citations

Machine Learning, Medicine, Idh1/2 Mutant +9

Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome

Annamaria Biczok, Rupert Egensperger, Andreas von Deimling et al. · Journal of Neuro-Oncology · 2019 · 48 citations

Neuro-oncology, Patient Outcome, Pathology +9